PR
PRE.US Prenetics Global Ltd
- Market cap
- USD 307M
- P/E
- -
- P/B
- 3.48x
- ROE
- -69.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is PRE.US undervalued?
Graham numberThe Graham number of Prenetics Global Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Prenetics Global Ltd fundamental analysis
No fundamental analysis for Prenetics Global Ltd yet.
Prenetics Global Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Prenetics Global Ltd
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Full company profilePrenetics Global Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Prenetics Global Ltd annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2013 | 2014 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 5.59B | 6.48B | 5.48B | 9.23M | 65.2M | 12.5M | 13.2M | 21.7M | 30.6M | 92.4M | 165M |
| Gross Profit | 860M | 1.36B | 669M | 2.72M | 26.3M | 3.60M | 3.62M | 8.83M | 15.4M | 48.8M | 107M |
| Operating Income | 833M | 1.33B | 642M | -20.8M | -995K | -56.7M | -66.0M | -51.9M | -48.1M | -38.1M | -63.3M |
| EBITDA | - | - | - | -18.6M | -1.42M | -209M | -218M | -47.9M | -51.6M | -32.2M | -62.5M |
| Net Income | 664M | 1.05B | 104M | -20.1M | -1.94M | -174M | -190M | -62.7M | -46.3M | -37.7M | -64.2M |
| EPS | 12 | - | - | -2.72 | -0.26 | -47 | -38 | -5.58 | -3.64 | -2.68 | -3.72 |
| Balance Sheet | |||||||||||
| Total Assets | 23.0B | 22.3B | 21.4B | 29.7M | 78.9M | 149M | 312M | 254M | 214M | 204M | 154M |
| Total Liabilities | 16.3B | 15.2B | 14.5B | 12.8M | 47.9M | 549M | 68.7M | 44.0M | 42.2M | 29.0M | 60.7M |
| Shareholders' Equity | 6.77B | 7.10B | 6.90B | 16.9M | 31.1M | -401M | 237M | 206M | 170M | 175M | 93.0M |
| Cash & Short-term Investments | 1.50B | 1.31B | 1.58B | 11.8M | 14.8M | 45.2M | 184M | 72.7M | 62.8M | 61.5M | 109M |
| Total Debt | - | - | - | 1.46M | 17.1M | 492M | 6.65M | 2.37M | 5.77M | 2.20M | 682K |
| Cash Flow | |||||||||||
| Operating Cash Flow | 827M | 853M | 319M | -1.88M | -2.88M | 13.4M | 14.5M | -13.8M | -28.9M | -21.8M | -55.2M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 374K | 3.06M | 11.4M | 6.34M | 912K | 1.07M | 208K | 31.3M |
| Free Cash Flow | - | - | - | -2.26M | -5.94M | 2.00M | 8.17M | -14.7M | -29.9M | -22.0M | -55.8M |
| Ratios | |||||||||||
| ROE | 9.8% | 14.8% | 1.5% | -119.1% | -6.2% | - | -80.3% | -30.4% | -27.2% | -21.6% | -69.0% |
| ROA | 2.9% | 4.7% | 0.5% | -67.8% | -2.5% | -117.2% | -61.0% | -24.7% | -21.7% | -18.5% | -41.8% |
| Net Profit Margin | 11.9% | 16.3% | 1.9% | -218.2% | -3.0% | -1,388.4% | -1,446.8% | -288.5% | -151.2% | -40.8% | -38.9% |
| Debt to Equity | - | - | - | 0.09x | 0.55x | - | 0.03x | 0.01x | 0.03x | 0.01x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Prenetics Global Ltd dividends
Prenetics Global Ltd has not paid dividends in the last 9 fiscal years.
Last stock split: 1:15 on Nov 14, 2023.
Who owns Prenetics Global Ltd
- Insiders 18.25%
- Institutions 15.97%
- Public & others 65.78%
- Shares outstanding 17.9M
- Free float 12.8M
Top funds holding PRE.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| State Street® SPDR® S&P® Intl Sm Cp ETF | 11.5K | 0.06% | 0.00% | Oct 2026 |
| Russell Inv U.S. Small Cap Equity ETF | 5.24K | 0.03% | 0.00% | Oct 2026 |
| Fidelity Nasdaq Composite Index | 3.53K | 0.02% | -64.38% | Aug 2026 |
| Schroder IPF HK and China Eq A Acc HKD | 3.41K | 0.02% | 0.00% | Sep 2026 |
| JHVIT Total Stock Market Index I | 279.00 | 0.00% | 0.00% | Sep 2026 |
| Avantis Pacific Equity ETF USD Acc | 8.00 | 0.00% | 0.00% | Oct 2026 |
Top institutions holding PRE.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Prospect Capital Advisors, LLC | 236K | 1.21% | 0.00% | Jun 2026 |
| Jane Street Group LLC | 225K | 1.15% | +433.57% | Jun 2026 |
| The Goldman Sachs Group Inc | 169K | 0.86% | -12.84% | Jun 2026 |
| Millennium Management LLC | 126K | 0.65% | -34.53% | Jun 2026 |
| Tenzing Global Management LLC | 125K | 0.64% | -37.50% | Jun 2026 |
| Marshall Wace Asset Management Ltd | 47.3K | 0.24% | -35.46% | Jun 2026 |
| Nomura Holdings Inc | 42.1K | 0.22% | -44.32% | Jun 2026 |
| Susquehanna International Group, LLP | 38.1K | 0.20% | +15.10% | Jun 2026 |
| UBS Group AG | 37.0K | 0.19% | +38.35% | Jun 2026 |
| XTX Topco Ltd | 30.5K | 0.16% | -8.77% | Jun 2026 |
| MY PURPOSEFUL WEALTH CORP | 28.1K | 0.14% | 0.00% | Jun 2026 |
| Qube Research & Technologies | 23.8K | 0.12% | +24.46% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 23.4K | 0.12% | +37.15% | Jun 2026 |
| Citadel Advisors Llc | 16.2K | 0.08% | 0.00% | Jun 2026 |
| Integrated Quantitative Investments LLC | 13.6K | 0.07% | 0.00% | Jun 2026 |
| Acadian Asset Management LLC | 12.6K | 0.06% | 0.00% | Sep 2026 |
| EntryPoint Capital LLC | 12.1K | 0.06% | 0.00% | Jun 2026 |
| Wells Fargo & Co | 10.0K | 0.05% | -88.21% | Jun 2026 |
| Operose Advisors LLC | 6.75K | 0.03% | 0.00% | Jun 2026 |
| State of Wyoming | 5.57K | 0.03% | +122.73% | Jun 2026 |
Prenetics Global Ltd company profile
- Company name
- Prenetics Global Ltd
- Ticker
- PRE.US
- ISIN
- KYG722451229
- Exchange
- USA Stocks
- Listed since
- May 18, 2022
- Sector
- Consumer Defensive
- Industry
- Insurance
- Employees
- 98
- Fiscal year end
- December
- Address
- Unit 703-706, K11 Atelier King?s Road, Quarry Bay, Hong Kong
- Phone
- 852 2210 9588
- Website
- prenetics.com
About Prenetics Global Ltd
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Prenetics Global Ltd management
1- Mr. Sheng Wu YeungCo-Founder, Chairperson & CEO · born 1979